|
End-of-day quote
Xetra
2024-02-05
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-28 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-30 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 67.96M 77.76M 63.87M 58.29M 109M 7.43B 109M 767M 296M 3.8B 292M 286M 12.24B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 67.96M 77.76M 63.87M 58.29M 109M 7.43B 109M 767M 296M 3.8B 292M 286M 12.24B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 2020-11-29 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 2022-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 2013-05-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 77.94M | |
| +0.94% | +4.95% | +87.70% | +41.91% | 369B | |
| +0.41% | +1.72% | +21.88% | -16.36% | 66.12B | |
| +3.30% | +8.36% | +47.07% | +190.95% | 12.65B | |
| -0.29% | +0.67% | -3.40% | -15.14% | 7.5B | |
| -0.90% | -1.54% | -30.91% | -10.89% | 4.42B | |
| -0.66% | -5.30% | -39.04% | +7.29% | 4.1B | |
| +2.65% | +9.76% | -23.27% | -6.94% | 3.1B | |
| +2.27% | +5.98% | -6.88% | +55.31% | 2.49B | |
| +0.11% | +2.94% | -21.01% | -31.33% | 1.98B | |
| Average | +0.71% | +3.17% | +3.57% | +23.87% | 52.36B | |
| Weighted average by Cap. | +0.89% | +4.43% | +72.02% | +35.47% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
